Behind the Design and Engineering of a Breakthrough Device for Stroke Rehab

Leaders from Neurolutions guest star on this episode of Let's Talk Medtech to talk about the design and engineering behind the recently authorized IpsiHand System for use in chronic stroke patients to facilitate muscle re-education through its brain-computer interface platform.

Amanda Pedersen

May 11, 2021

1 Min Read
Untitled design-61_0.png

medical device design

As MD+DIreported last month, FDA recently authorized the IpsiHand System, pictured above. 

The IpsiHand is a breakthrough device for patients 18 and older undergoing stroke rehabilitation to facilitate muscle re-education, and for maintaining or increasing range of motion. The Neurolutions IpsiHand Upper Extremity Rehabilitation System is a brain-computer interface device designed to assist in rehabilitation for stroke patients with upper extremity (hand, wrist, and arm) disability.

Neurolutions CEO Leo Petrossian, PhD, and Eric C. Leuthardt, MD, the company's co-founder and chief scientific officer, joined us for this episode of Let's Talk Medtech to share some insight into the design and engineering considerations for the device, as well as some lessons learned regarding FDA's breakthrough device designation pathway. Click the player below to listen to the conversation.

For more information about the IpsiHand System, visit the Neurolutions' website.

About the Author(s)

Amanda Pedersen

Amanda Pedersen is a veteran journalist and award-winning columnist with a passion for helping medical device professionals connect the dots between the medtech news of the day and the bigger picture. She has been covering the medtech industry since 2006.

Sign up for the QMED & MD+DI Daily newsletter.

You May Also Like